Repository logo
 

Cytosine-5 RNA Methylation Regulates Neural Stem Cell Differentiation and Motility

Published version
Peer-reviewed

Change log

Authors

Flores, JV 
Cordero-Espinoza, L 
Oeztuerk-Winder, F 
Andersson-Rolf, A 
Selmi, T 

Abstract

Loss-of-function mutations in the cytosine-5 RNA methylase NSUN2 cause neurodevelopmental disorders in humans, yet the underlying cellular processes leading to the symptoms that include microcephaly remain unclear. Here, we show that NSUN2 is expressed in early neuroepithelial progenitors of the developing human brain, and its expression is gradually reduced during differentiation of human neuroepithelial stem (NES) cells in vitro. In the developing Nsun2/ mouse cerebral cortex, intermediate progenitors accumulate and upper-layer neurons decrease. Loss of NSUN2-mediated methylation of tRNA increases their endonucleolytic cleavage by angiogenin, and 5' tRNA fragments accumulate in Nsun2/ brains. Neural differentiation of NES cells is impaired by both NSUN2 depletion and the presence of angiogenin. Since repression of NSUN2 also inhibited neural cell migration toward the chemoattractant fibroblast growth factor 2, we conclude that the impaired differentiation capacity in the absence of NSUN2 may be driven by the inability to efficiently respond to growth factors.

Description

Keywords

neurodevelopmental disorder, RNA methylation, 5-methylcytosine, NSUN2, neural stem cells

Journal Title

Stem Cell Reports

Conference Name

Journal ISSN

2213-6711
2213-6711

Volume Title

8

Publisher

Elsevier
Sponsorship
Medical Research Council (G0801904)
Medical Research Council (MC_PC_12009)
Medical Research Council (MR/M01939X/1)
European Research Council (310360)
This work was funded by Cancer Research UK (CR-UK C10701/A15181 ), Worldwide Cancer Research ( 15-0168 ), the Medical Research Council (MRC MR/M01939X/1 ), the European Research Council (ERC 310360 ), and EMBO. Research in M.F.'s laboratory was supported by a core support grant from the Wellcome Trust and MRC to the Wellcome Trust-Medical Research Cambridge Stem Cell Institute.